Edition:
United Kingdom

vTv Therapeutics Inc (VTVT.OQ)

VTVT.OQ on NASDAQ Stock Exchange Capital Market

2.67USD
18 Jan 2019
Change (% chg)

$-0.04 (-1.48%)
Prev Close
$2.71
Open
$2.69
Day's High
$2.96
Day's Low
$2.62
Volume
246,525
Avg. Vol
657,616
52-wk High
$8.37
52-wk Low
$0.65

Chart for

About

vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of orally administered small molecule drug candidates. Its drug candidate for the treatment of Alzheimer's disease (AD) is azeliragon (TTP488), an orally administered, small molecule antagonist targeting... (more)

Overall

Beta: --
Market Cap(Mil.): $204.09
Shares Outstanding(Mil.): 32.81
Dividend: --
Yield (%): --

Financials

  VTVT.OQ Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -1.67 -- --
ROI: -134.79 8.99 14.48
ROE: -- 10.13 15.99

Earnings vs. Estimates